Author:
Shuvaeva V. N.,Gorshkova O. P.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. I. A. Gonchar, Yu. I. Stepanova, and I. S. Prudyvus, Biochemical Predictors and Markers of Ischemic Stroke, V. S. Kamyshnikov (ed.), Medical Academy of Postgraduate Education, Minsk (2013).
2. F. Denorme and S. F. De Meyer, “The VWF-GPIb axis in ischaemic stroke: lessons from animal models,” J. Thromb. Haemost., 116, No. 04, 597–604 (2016), https://doi.org/10.1160/TH16-01-0036.
3. M. M. Khan, D. G. Motto, S. R. Lentz, and A. K. Chauhan, “ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice,” J. Thromb. Haemost., 10, No. 8, 1665–1671 (2012), https://doi.org/10.1111/j.1538-7836.2012.04822.x.
4. N. Dhanesha, P. Prakash, P. Doddapattar, et al., “Endothelial cell-derived von Willebrand factor is the major determinant that mediates von Willebrand factor-dependent acute ischemic stroke by promoting postischemic thrombo-infl ammation,” Arterioscler. Thromb. Vasc. Biol., 36, No. 9, 1829–1837 (2016), https://doi.org/10.1161/ATVBAHA.116.
5. Z. A. Suslina, M. M. Tanashyan, M. A. Domashenko, et al., “Endothelial dysfunction in patients with ischemic stroke,” Ann. Klin. Eksperim. Nevrol., 2, No. 1, 4–11 (2008).